Filter News
Area of Research
- (-) Biology and Environment (26)
- Advanced Manufacturing (3)
- Biological Systems (1)
- Clean Energy (24)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (4)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (2)
- Isotopes (5)
- Materials (43)
- Materials for Computing (7)
- National Security (17)
- Neutron Science (100)
- Nuclear Science and Technology (7)
- Supercomputing (37)
News Topics
- (-) Biomedical (16)
- (-) Machine Learning (8)
- (-) Neutron Science (4)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (1)
- Artificial Intelligence (9)
- Big Data (9)
- Bioenergy (45)
- Biology (73)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (11)
- Clean Water (11)
- Climate Change (40)
- Composites (5)
- Computer Science (19)
- Coronavirus (13)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (19)
- Energy Storage (7)
- Environment (89)
- Exascale Computing (4)
- Frontier (3)
- Fusion (1)
- Grid (3)
- High-Performance Computing (20)
- Hydropower (8)
- Isotopes (2)
- Materials (12)
- Materials Science (6)
- Mathematics (3)
- Mercury (7)
- Microscopy (10)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (3)
- Net Zero (2)
- Nuclear Energy (1)
- Partnerships (5)
- Physics (2)
- Polymers (2)
- Renewable Energy (1)
- Security (2)
- Simulation (14)
- Summit (10)
- Sustainable Energy (30)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
![Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-01/AAAS_fellows_resize_0.jpg?h=e91a75a9&itok=y20mbH61)
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
![This protein drives key processes for sulfide use in many microorganisms that produce methane, including Thermosipho melanesiensis. Researchers used supercomputing and deep learning tools to predict its structure, which has eluded experimental methods such as crystallography. Credit: Ada Sedova/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-01/thermosipho_collabfold2_0.jpg?h=3432ff3c&itok=4xhLbjKZ)
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory and the Georgia Institute of Technology is using supercomputing and revolutionary deep learning tools to predict the structures and roles of thousands of proteins with unknown functions.
![Researchers studying secondary metabolites in the fungus Aspergillus flavus, pictured, found unique mixes of metabolites corresponding to genetically distinct populations. The finding suggests local environmental conditions play a key role in secondary metabolite production, influencing the discovery of drugs and other useful compounds. Credit: Tomás Allen Rush/ORNL, U.S. Dept. of Energy.](/sites/default/files/styles/list_page_thumbnail/public/2021-07/DSC0351.jpg?h=b2d9f031&itok=PNgYY5eW)
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
![The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.](/sites/default/files/styles/list_page_thumbnail/public/2021-05/DOE%20ECRP%20winners_1.jpg?h=d1cb525d&itok=qW3-KeMF)
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Distinguished Inventors](/sites/default/files/styles/list_page_thumbnail/public/2020-12/inventors.jpg?h=4631f1c1&itok=xhAGY0kv)
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
![An organic solvent and water separate and form nanoclusters on the hydrophobic and hydrophilic sections of plant material, driving the efficient deconstruction of biomass. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/dark_image_small.png?h=2e111cc1&itok=drKqW05b)
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.